Erratum: Latent autoimmune diabetes in adults is perched between type 1 and type 2: Evidence from adults in one region of Spain [Diabetes/Metabolism Research and Reviews, 29, 6, (2013) 446-451] DOI: 10.1002/dmrr.2411;Latent autoimmune diabetes in adults is perched between type 1 and type 2: Evidence from adults in one region of spain

Diabetes/Metabolism Research and Reviews

Volumn 29, Issue 6, 2013, Pages 446-451

  Mollo, Angels ^a   Hernandez, Marta ^b,c   Marsal, Josep R ^d,e,f   Esquerda, Aureli ^b   Rius, Ferran ^b,c   Blanco Vaca, Francisco ^f,g   Verdaguer, Joan ^c,d   Pozzilli, Paolo ^h,i   de Leiva, Alberto ^f,j,k   Mauricio, Didac ^b,c  

^a INSTITUT CATALÀ DE LA SALUT   (Spain)

^b HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

^c UNIVERSITY OF LLEIDA   (Spain)

^d UNIVERSITY OF LLEIDA   (Spain)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^f UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^g INSTITUTO DE SALUD CARLOS III   (Spain)

^h UNIVERSITY CAMPUS BIO MEDICO   (Italy)

ⁱ QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^j HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^k BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

more..

Author keywords

C peptide; Glutamic acid decarboxylase antibodies; Latent autoimmune diabetes in adults; Metabolic syndrome; Type 1 diabetes mellitus; Type 2 diabetes mellitus

Indexed keywords

C PEPTIDE; CHOLESTEROL; GLUCOSE; GLUTAMATE DECARBOXYLASE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PANCREAS ISLET CELL ANTIBODY; TRIACYLGLYCEROL;

ADULT; AGE; ANTIBODY TITER; ANTIHYPERTENSIVE THERAPY; ARTICLE; AUTOIMMUNE DISEASE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE DURATION; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN TREATMENT; LATENT AUTOIMMUNE DIABETES IN ADULT; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SPAIN; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

C-PEPTIDE; GLUTAMIC ACID DECARBOXYLASE ANTIBODIES; LATENT AUTOIMMUNE DIABETES IN ADULTS; METABOLIC SYNDROME; TYPE 1 DIABETES MELLITUS; TYPE 2 DIABETES MELLITUS;

ADULT; AGED; AUTOANTIBODIES; AUTOIMMUNITY; C-PEPTIDE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; SPAIN;

EID: 84883636876     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2476     Document Type: Erratum

References (22)

1. American Diabetes Association. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26 Suppl 1:S5-S20. DOI: 10.2337/diacare.26.2007.S5.
2. Leslie RD, Kolb H, Schloot NC, et al. Diabetes classification: grey zones, sound and smoke: Action LADA 1. Diabetes Metab Res Rev 2008; 24(7): 511-9. doi:10.1002/dmrr.877.
3. Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles W, Mackay IR. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a noninsulin-dependent onset of disease. Diabetes 1993; 42(2): 359-362.
4. Fourlanos S, Dotta F, Greenbaum CJ, et al. Latent autoimmune diabetes in adults (LADA) should be less latent. Diabetologia 2005; 48(11): 2206-2212. doi:10.1007/s00125-005-1960-7.
5. Gale EA. Latent autoimmune diabetes in adults: a guide for the perplexed. Diabetologia 2005; 48: 2195-2199. doi:10.1007/s00125-005-1954-5.
6. Rolandsson O, Palmer JP. Latent autoimmune diabetes in adults (LADA) is dead: long live autoimmune diabetes!. Diabetologia 2010; 53(7): 1250-1253. doi:10.1007/s00125-010-1713-0.
7. Stenström G, Gottsäter A, Bakhtadze E, Berger B, Sundkvist G. Latent autoimmune diabetes in adults definition, prevalence, β-cell function, and treatment. Diabetes 2005; 54(Suppl 2): S68-S72. doi:10.2337/diabetes.54.suppl_2.S68.
8. Brophy S, Davies H, Mannan S, Brunt H, Williams R. Interventions for latent autoimmune diabetes (LADA) in adults. Cochrane Database Syst Rev 2011; 9: CD006165. doi:10.1002/14651858.CD006165.pub3.
9. Brophy S, Yderstraede K, Mauricio D, et al. Time to insulin initiation cannot be used in defining latent autoimmune diabetes of the adult. Diabetes Care 2008; 31(3): 439-441. doi:10.2337/dc07-1308.
10. Hawa MI, Thivolet C, Mauricio D, et al. Metabolic syndrome and autoimmune diabetes: action LADA 3. Diabetes Care 2009; 32(1): 160-164. doi:10.2337/dc08-1419.
11. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-2497. DOI: 10.1001/jama.285.19.2486.
12. Palomer X, Mauricio D, Rodríguez-Espinosa J, et al. Evaluation of two nonisotopic immunoassays for determination of glutamic acid decarboxylase and tyrosine phosphatase autoantibodies in serum. Clin Chem 2004; 50(8): 1378-82. doi:10.1373/clinchem.2004.031799.
13. Chen S, Willis J, Maclean C, et al. Sensitive non-isotopic assays for autoantibodies to IA-2 and to a combination of both IA-2 and GAD65. Cin Chim Acta 2005; 357: 74-83. doi:10.1016/j.cccn.2005.02.006.
14. Hosszúfalusi N, Vatay A, Rajczy K, et al. Similar genetic features and different islet cell autoantibody pattern of latent autoimmune diabetes in adults (LADA) compared with adult-onset type 1 diabetes with rapid progression. Diabetes Care 2003; 26(2): 452-457. doi:10.2337/diacare.26.2.452.
15. Rosário PW, Reis JS, Amim R, et al. Comparison of clinical and laboratory characteristics between adult-onset type 1 diabetes and latent autoimmune diabetes in adults. Diabetes Care 2005; 28(7): 1803-4. doi:10.2337/diacare.28.7.1803.
16. Tuomi T, Carlsson A, Li H, et al. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 1999; 48: 150-157.
17. Zinman B, Kahn SE, Haffner SM, O'Neill MC, Heise MA, Freed MI. Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with type 2 diabetes in North America and Europe. Diabetes 2004; 53: 3193-3200. doi:10.2337/diabetes.53.12.3193.
18. Buzzetti R, Di Pietro S, Giaccari A, et al. High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes. Diabetes Care 2007; 30(4): 932-8. doi:10.2337/dc06-1696.
19. Radtke MA, Midthjell K, Nilsen TI, Grill V. Heterogeneity of patients with latent autoimmune diabetes in adults: linkage to autoimmunity is apparent only in those with perceived need for insulin treatment: results from the Nord-Trøndelag Health (HUNT) study. Diabetes Care 2009; 32(2): 245-50. doi:10.2337/dc08-1468.
20. Genovese S, Bazzigaluppi E, Gonçalves D, et al. Clinical phenotype and β-cell autoimmunity in Italian patients with adult-onset diabetes. Eur J Endocrinol 2006; 154: 441-447. doi:10.1530/eje.1.02115.
21. Rosário PW, Reis JS, Fagundes TA, et al. Latent autoimmune diabetes in adults (LADA): usefulness of anti-GAD antibody titers and benefit of early insulinization. Arq Bras Endocrinol Metab 2007; 51(1): 52-58.
22. Maioli M, Pes GM, Delitala G, et al. Number of autoantibodies and HLA genotype, more than high titers of glutamic acid decarboxylase autoantibodies, predict insulin dependence in latent autoimmune diabetes of adults. Eur J Endocrinol 2010; 163(4): 541-9. doi:10.1530/EJE-10-0427.